期刊文献+

不同类型自身抗体对类风湿关节炎骨破坏程度的影响 被引量:10

Effects of different types of autoantibodies on bone destruction in rheumatoid arthritis
原文传递
导出
摘要 目的:探讨不同类型自身抗体及其他流行病学因素对类风湿关节炎( rheumatoid ar-thritis,RA)骨破坏严重程度的影响,以期发现RA骨破坏的独立危险因素。方法随机选取445例RA患者作为研究对象,收集患者流行病学资料,采用ELISA方法检测血清中类风湿因子( rheumatoid factor,RF)、抗环瓜氨酸肽抗体( anti-cyclic citrullinated peptide antibody,抗CCP抗体)和抗瓜氨酸化α烯醇化酶多肽1抗体[anti-citrullinated alpha-enolase peptide 1(CEP-1) antibody,抗CEP-1抗体]三种自身抗体的水平;采用修订版Sharp评分法( Sharp/van der Heijde score)对患者双手X线正位平片进行关节影像学评分。采用Mann-Whitney U检验分析两组间Sharp评分的差异;采用协方差分析法排除病程因素对组间Sharp评分比较的影响;采用单因素或多因素线性回归分析法评估导致关节影像学改变的可能危险因素及独立危险因素。结果单因素回归分析提示, RA患者的性别(女性,β=0.100, P=0.035)、病程(β=0.498, P=3.26×10^-29)、RF(β=0.096, P=0.042)、抗CCP抗体(β=0.202, P=1.74×10^-5)、抗CEP-1抗体(β=0.148, P=0.017)以及抗CCP和抗CEP-1抗体联合检测阳性(β=0.157, P=1.42×10^-3)为 RA 患者关节破坏的潜在危险因素。而患者发病年龄晚(β=-0.312, P=1.60×10^-11)及吸烟史(β=-0.121, P=0.018)可能为RA患者骨破坏的保护因素。进一步多因素回归分析表明,患者的病程和抗 CCP 抗体为其发生骨破坏的独立危险因素(病程:P=2.24×10^-15,抗CCP抗体:P=0.012)。抗CCP抗体对RA骨破坏的影响主要发生在病程的中期(P=0.014)和晚期(P=0.023)。结论 RA患者的性别(女性)、病程、RF、抗CCP抗体和抗CEP-1抗体均为RA骨破坏的可能危险因素;抗瓜氨酸化抗体对RA骨破坏的作用主要发生在病程的中晚期;RA患者发病年龄越早,其骨破坏程度亦越严重。病程和抗CCP抗体为RA骨破坏 Objective To investigate any potential and independent demographic and serologic risk factors contributing to bone destruction in patients with rheumatoid arthritis ( RA) . Methods A total of 445 patients with RA were recruited in this study. Three autoantibodies including rheumatoid factor ( RF) , anti-cyclic citrullinated peptide antibody ( anti-CCP antibody) and anti-citrullinated alpha-enolase peptide 1 antibody ( anti-CEP-1 antibody) were quantified by using specific ELISA kits. The hand radiographs of all subjects were graded by using the modified Sharp/van der Heijde score ( Sharp score) . The potential and in-dependent risk factors were assessed by using univariate linear regression analyses and the stepwise multiple regression analysis, respectively. Results Based upon the univariate regression analyses, 7 covariates were identified as the potential risk factors for bone destruction in patients with RA, which were female (β=0. 100, P=0. 035), longer disease duration (β=0. 498, P=3. 26×10-^29), RF (β=0. 096, P=0. 042), younger age at onset (β=-0. 312, P=1. 60 × 10^-11 ), anti-CCP antibody positive (β=0. 202, P=1.74×10^-5), anti-CEP-1 antibody positive (β=0.148, P=0.017) and positive for either anti-CCP or anti-CEP-1 antibodies (β=0. 157, P=1. 42×10-^3). However, smoking (β=-0. 121, P=0. 018) were identi-fied as the potential protective factors. The multiple regression analysis indicated that the longer disease du-ration (P=2. 24×10^-15) and anti-CCP antibody positive (P=0. 012) were independent risk factors for bone destruction. Conclusion Female, longer disease duration, younger age at onset, RF, anti-CCP and anti-CEP-1antibodies are potential risk factors for bone damage in patients with RA. Moreover, longer disease du-ration and anti-CCP antibody are two independent risk factors contributing to bone destruction in RA.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2016年第8期572-578,共7页 Chinese Journal of Microbiology and Immunology
关键词 类风湿关节炎 类风湿因子 抗CCP抗体 抗CEP-1抗体 Sharp评分 Rheumatoid arthritis Rheumatoid factor Anti-CCP antibody Anti-CEP-1 antibody Sharp score
  • 相关文献

参考文献30

  • 1Miossec P. Rheumatoid arthritis: still a chronic disease[ J]. Lan- cet, 2013, 381 (9870): 884-886. 被引量:1
  • 2ttecht C, Englbrecht M, Rech J, et al. Additive effect of anti-cit- rullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA[J]. Ann Rheum Dis, 2015, 74(12) : 2151- 2156. 被引量:1
  • 3Ingegnoli F, Castelli R, Guahierotti R. Rheumatoid factors : clini- cal applications[J]. Dis Markers, 2013, 35(6) : 727-734. 被引量:1
  • 4Simard JF, Holmqvist M. Rheumatoid factor positivity in the gen- eral population[Jl. BMJ, 2012, 345: e5841. 被引量:1
  • 5Hakala M, Sajanti E, Ikaheimo I, et al. High prevalence of rheu- matoid factor in community-based series of patients with rheumatoid arthritis meeting the new (1987) ARA criteria: RF-negative non- erosive rheumatoid arthritis is very rare[ J]. Scand J Rheumatol, 1998, 27(5): 368-372. 被引量:1
  • 6van Venrooij WJ, van Beers JJ, Pruijn GJ. Anti-CCP antibodies: the past, the present and the future [J]. Nat Rev Rheumatol, 2011, 7(7) : 391-398. 被引量:1
  • 7Kinloch A, Tatzer V, Wait R, et al. Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis [J]. Arthritis Res Ther, 2005, 7(6) : R1421-1429. 被引量:1
  • 8Arnett FC, Edworthy SM, Bloch DA, et al. The american rheuma- tism association 1987 revised criteria for the classification of rheu- matoid arthritis[ J~. Arthritis Rheum, 1988, 31 (3) : 315-324. 被引量:1
  • 9Prevoo ML, van't Hof MA, Kuper HI/, et al. Modified disease ac- tivity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis[ J~. Arthritis Rheum, 1995, 38 (1) : 44-48. 被引量:1
  • 10van der Heijde D. How to read radiographs according to the Sharp/ van der I/eijde method [ J ]. J Rheumatol, 1999, 26 (3) : 743- 745. 被引量:1

同被引文献97

引证文献10

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部